FeesSafety
Pluang+

Merck KGaA to acquire Rapid Micro Biosystems, boosting automation in pharmaceutical quality control

Company Fundamentals
16 Nov 2026, 16:57 WIB
GlobeNewsWire
View Source
Bullish
Merck KGaA to acquire Rapid Micro Biosystems, boosting automation in pharmaceutical quality control

Merck KGaA, Darmstadt, Germany, has signed a definitive agreement to acquire Rapid Micro Biosystems for $0.75 per share in cash. This acquisition will enhance Merck's pharmaceutical quality-control offerings by integrating Rapid Micro Biosystems' Growth Direct® platform, which automates microbial testing to deliver faster and more reliable results. The move supports Merck's strategic focus on integrated workflow solutions and aims to improve efficiency and data integrity in pharmaceutical manufacturing. The deal is expected to close in December 2026, pending customary conditions.

Merck & Co., Inc. (MRK) shares are trading at USD 148.71 on Pluang as of Nov 16, 2026, 22:11 WIB. The stock has seen a modest 0.64% increase in the last day. Its market capitalization stands at $364.26 billion, reflecting strong investor interest in the health sector.

More News (MRK)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App